US 8691868
Neprilysin inhibitors
granted A61KA61K31/16A61K31/164
Quick answer
US patent 8691868 (Neprilysin inhibitors) held by Theravance, Inc. expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K31/16, A61K31/164, A61K31/165, A61K31/166